Studies have shown that MerTK-positive TAMs typically exhibit significant immune-suppressive characteristics, inhibiting T cell function by expressing immune checkpoint molecules such as PD-L1 (98), thereby promoting tumor immune escape. This evidence concerns the gene MERTK and neoplasm.